JP2004536585A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536585A5 JP2004536585A5 JP2002587582A JP2002587582A JP2004536585A5 JP 2004536585 A5 JP2004536585 A5 JP 2004536585A5 JP 2002587582 A JP2002587582 A JP 2002587582A JP 2002587582 A JP2002587582 A JP 2002587582A JP 2004536585 A5 JP2004536585 A5 JP 2004536585A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- tirap
- seq
- tlr4
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 53
- 108090000765 processed proteins & peptides Proteins 0.000 claims 53
- 229920001184 polypeptide Polymers 0.000 claims 49
- 101000637726 Homo sapiens Toll/interleukin-1 receptor domain-containing adapter protein Proteins 0.000 claims 39
- 102100032120 Toll/interleukin-1 receptor domain-containing adapter protein Human genes 0.000 claims 38
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 24
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims 24
- 108091033319 polynucleotide Proteins 0.000 claims 24
- 239000002157 polynucleotide Substances 0.000 claims 24
- 102000040430 polynucleotide Human genes 0.000 claims 24
- 210000004027 cell Anatomy 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 16
- 238000000034 method Methods 0.000 claims 16
- 239000005557 antagonist Substances 0.000 claims 10
- 239000002773 nucleotide Substances 0.000 claims 10
- 125000003729 nucleotide group Chemical group 0.000 claims 10
- 238000012216 screening Methods 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 6
- 230000011664 signaling Effects 0.000 claims 6
- 102000010168 Myeloid Differentiation Factor 88 Human genes 0.000 claims 5
- 108010077432 Myeloid Differentiation Factor 88 Proteins 0.000 claims 5
- 239000013604 expression vector Substances 0.000 claims 5
- 230000035772 mutation Effects 0.000 claims 5
- 150000003384 small molecules Chemical class 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 238000007877 drug screening Methods 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 230000009261 transgenic effect Effects 0.000 claims 2
- 108700031308 Antennapedia Homeodomain Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 108050006617 Interleukin-1 receptor Proteins 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 230000006801 homologous recombination Effects 0.000 claims 1
- 238000002744 homologous recombination Methods 0.000 claims 1
- 102000044006 human TIRAP Human genes 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 239000000816 peptidomimetic Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28981501P | 2001-05-09 | 2001-05-09 | |
| US28973801P | 2001-05-09 | 2001-05-09 | |
| US28986601P | 2001-08-29 | 2001-08-29 | |
| US10139802A | 2002-03-19 | 2002-03-19 | |
| PCT/US2002/014915 WO2002090520A2 (en) | 2001-05-09 | 2002-05-09 | Toll/interleukin-1 receptor adaptor protein (tirap) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536585A JP2004536585A (ja) | 2004-12-09 |
| JP2004536585A5 true JP2004536585A5 (https=) | 2005-12-22 |
Family
ID=27493201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002587582A Pending JP2004536585A (ja) | 2001-05-09 | 2002-05-09 | トル／インターロイキン−１受容体アダプタータンパク質（ｔｉｒａｐ） |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US6960343B2 (https=) |
| EP (1) | EP1401281A4 (https=) |
| JP (1) | JP2004536585A (https=) |
| AU (1) | AU2002305539A1 (https=) |
| CA (1) | CA2446458A1 (https=) |
| WO (1) | WO2002090520A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7651857B2 (en) * | 2000-12-22 | 2010-01-26 | The Mathilda And Terence Kennedy Institute Of Rheumatology Trust | Methods for enhancing antigen presentation |
| US7220723B2 (en) | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| JP2004073073A (ja) * | 2002-08-16 | 2004-03-11 | Japan Science & Technology Corp | エンドトキシン及びリポタンパク・リポペプチド不応答性モデル非ヒト動物 |
| US20040191833A1 (en) * | 2003-03-25 | 2004-09-30 | 3M Innovative Properties Company | Selective activation of cellular activities mediated through a common toll-like receptor |
| US7696169B2 (en) | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| US20050013812A1 (en) * | 2003-07-14 | 2005-01-20 | Dow Steven W. | Vaccines using pattern recognition receptor-ligand:lipid complexes |
| AU2004272607B2 (en) | 2003-09-11 | 2008-11-06 | Cornerstone Therapeutics Inc. | Monoclonal antibodies against HMGB1 |
| US20060002941A1 (en) * | 2004-01-23 | 2006-01-05 | Vievax Corp. | Compositions comprising immune response altering agents and methods of use |
| US20050244410A1 (en) * | 2004-04-29 | 2005-11-03 | Ashlyn Bassiri | Toll-like receptor 9 effector agents and uses thereof |
| BRPI0519148A2 (pt) | 2004-12-20 | 2008-12-30 | Sigma Tau Ind Farmaceuti | inibidores de homodimerizaÇço de myd88 |
| RU2461390C2 (ru) * | 2005-01-28 | 2012-09-20 | Галенбио, Инк. | Иммунологически активные составы |
| WO2006113530A2 (en) * | 2005-04-15 | 2006-10-26 | University Of Maryland, Baltimore | Selective inhibition of tlr4 signaling |
| CA2694046C (en) * | 2007-07-26 | 2023-09-12 | Revance Therapeutics, Inc. | Cationic peptides and compositions thereof |
| EP2262480B1 (en) | 2008-03-04 | 2018-02-14 | Liquidia Technologies, Inc. | Immunomodulator particles |
| EP2625196B1 (en) | 2010-10-05 | 2016-03-23 | Kemijski Institut | Fusion polypeptides comprising tir and dimerization domain for modulation of tlr/innate immunity signaling |
| KR101566107B1 (ko) | 2014-04-18 | 2015-11-05 | 영남대학교 산학협력단 | Tlr6 tir 도메인의 ３차 구조 및 이를 이용한 약물 스크리닝 방법 |
| DK3653221T5 (da) | 2015-02-19 | 2024-08-26 | Compugen Ltd | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder |
| US10550173B2 (en) | 2015-02-19 | 2020-02-04 | Compugen, Ltd. | PVRIG polypeptides and methods of treatment |
| EP3095444A1 (en) | 2015-05-20 | 2016-11-23 | Dublin City University | A method of treating peripheral inflammatory disease |
| IL317989A (en) | 2016-08-17 | 2025-02-01 | Compugen Ltd | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof |
| JP7348072B2 (ja) | 2017-06-01 | 2023-09-20 | コンピュジェン リミテッド | 三重併用抗体療法 |
| KR20200084569A (ko) * | 2019-01-03 | 2020-07-13 | 주식회사 젠센 | Tlr4 신호전달 경로를 억제하는 펩타이드 및 그 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6271349B1 (en) * | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
| US6399584B1 (en) * | 1998-03-18 | 2002-06-04 | Institute Curie | Pharmaceutical composition containing ezrin mutated on tyrosine 353 |
| US7029861B1 (en) * | 1998-09-15 | 2006-04-18 | Board Of Regents, The University Of Texas System | LPS-response gene compositions and methods |
| ATE442774T1 (de) | 1999-01-14 | 2009-10-15 | Japan Science & Tech Agency | Myod-knockout maus als bakterienzellwandbestandteil-unansprechender tiermodell |
| AU4201000A (en) * | 1999-04-05 | 2000-10-23 | Incyte Pharmaceuticals, Inc. | Molecules of the immune system |
| US6506769B2 (en) * | 1999-10-06 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| AU2001263236A1 (en) | 2000-05-17 | 2001-11-26 | Immunex Corporation | Human myd88 adapter-like protein and functional fragments thereof |
-
2002
- 2002-05-09 WO PCT/US2002/014915 patent/WO2002090520A2/en not_active Ceased
- 2002-05-09 EP EP02734367A patent/EP1401281A4/en not_active Withdrawn
- 2002-05-09 AU AU2002305539A patent/AU2002305539A1/en not_active Abandoned
- 2002-05-09 CA CA002446458A patent/CA2446458A1/en not_active Abandoned
- 2002-05-09 JP JP2002587582A patent/JP2004536585A/ja active Pending
- 2002-07-03 US US10/188,947 patent/US6960343B2/en not_active Expired - Fee Related
-
2005
- 2005-09-16 US US11/229,066 patent/US7285535B2/en not_active Expired - Lifetime
-
2007
- 2007-10-15 US US11/974,728 patent/US20080096250A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004536585A5 (https=) | ||
| Obara et al. | Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function | |
| ES2625316T3 (es) | Neuquinasa, una proteína corriente abajo de neuregulina | |
| WO2000075655A1 (fr) | Procede de criblage avec cd100 | |
| JPH10508486A (ja) | 修飾神経ペプチドｙレセプター | |
| JPH04506752A (ja) | チロトロピンレセプター活性を有するポリペプチド、このレセプターとポリペプチドとをコードする核酸、そしてこのようなペプチドの利用 | |
| US5759788A (en) | High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them | |
| US20040167066A1 (en) | Cleavage and polyadenylation complex of precursor mrna | |
| AU1395399A (en) | Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis | |
| JP2000508071A (ja) | Ｗｗドメインを有する新規ポリペプチドの同定と単離およびその利用方法 | |
| WO1998000552A2 (en) | Receptor tyrosine phosphatase, and uses related thereto | |
| US7125666B2 (en) | Collagen XXII, a novel human collagen and uses thereof | |
| CN105143256A (zh) | 血管生成素-2特异性Tie2受体 | |
| US20060110391A1 (en) | Compositions and methods for the treatment of body weight disorders, including obesity | |
| JP2005518187A5 (https=) | ||
| Lenk et al. | Ubiquitinated aldolase B accumulates during starvation‐induced lysosomal proteolysis | |
| US20060292639A1 (en) | Splice variant of the vanilloid receptor VR1A | |
| JP2002542774A (ja) | タンパク質−タンパク質相互作用 | |
| US20060123492A1 (en) | Methods of identifying modulators of NMUR2-mediated activity | |
| US20040213738A1 (en) | CIRL3-Like proteins, nucleic acids, and methods of modulating CIRL3-L-mediated activity | |
| US20100015654A1 (en) | Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells | |
| WO2010020004A1 (en) | Compositions and methods for inhibition of adipogenesis and the treatment of obesity | |
| US20020090710A1 (en) | 57800, a novel human cadherin and uses thereof | |
| Takahashi et al. | Identification of the cell-type-specific ER membrane protein Tanmp expressed in hypothalamic tanycytes and subsets of neurons | |
| KR20030074675A (ko) | 신규한 글루타메이트 수용체 조절 단백질 및 핵산 분자 및이의 용도 |